Digestive Enzymes and Alpha galactosidase
Natural health product licensed in Canada
- Other names
- Complete Digestive Enzymes, Digestive Enzymes
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80107993
- Status
- Active licence
- Licence date
- 8 February 2021
- Revision date
- 4 November 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 150 FCC GalU | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 20 FCC SU | Not calculated |
| Serrapeptase Source : Serratia marcescens E-15 - Cellule Entiière | 187.5 SPU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 750 FCC PU | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 22,100 FCC HUT | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 90 FCC CU | Not calculated |
Non-medicinal ingredients
Acide stéarique, Eau, Gélatine, Silice, Cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 3 Tous les jours ; maximum: 10 Tous les jours |
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme(s). Digestive enzyme. Digestive enzyme/lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea). Digestive aid to help digest proteins. Digestive enzyme that helps digest proteins. Proteolytic enzyme. Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Helps reduce gas production/flatulence following a meal rich in oligosaccharides/fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Digestive aid. Helps digest proteins. Helps digest proteins and helps prevent symptoms of lactose intolerance. Helps digest proteins & lactose. Helps digest proteins and foods containing lactose (such as dairy foods like milk, cheese, ice cream). Helps reduce gas following a meal rich in fermentable carbohydrates. Helps reduce gas production and/or prevent gastrointestinal intolerance following a meal rich in fermentable carbohydrates (such as vegetables, beans, pulses, legumes, and whole grains). Helps reduce gas from fermentable carbohydrates.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80107993
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serrapeptase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.